| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.2 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.31 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.2 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |